• 1
    Knowler, W. C., Narayan, K. M., Hanson, R. L., et al (1995) Preventing non-insulin-dependent diabetes. Diabetes 44: 483488.
  • 2
    Knowler, W. C., Barrett-Connor, E., Fowler, S. E., et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393403.
  • 3
    Tuomilehto, J., Lindstrom, J., Eriksson, J. G., et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 13431350.
  • 4
    Wannamethee, S. G., Shaper, A. G. (2001) Physical activity in the prevention of cardiovascular disease: an epidemiological perspective. Sports Med 31: 101114.
  • 5
    Hotamisligil, G. S. (1999) The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 245: 621625.
  • 6
    Kern, P. A., Ranganathan, S., Li, C., Wood, L., Ranganathan, G. (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280: E745E751.
  • 7
    Hauner, H., Bender, M., Haastert, B., Hube, F. (1998) Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord 22: 12391243.
  • 8
    Pannacciulli, N., Cantatore, F. P., Minenna, A., Bellacicco, M., Giorgino, R., De Pergola, G. (2001) C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes Relat Metab Disord 25: 14161420.
  • 9
    Vozarova, B., Weyer, C., Hanson, K., Tataranni, P. A., Bogardus, C., Pratley, R. E. (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9: 414417.
  • 10
    Ridker, P. M., Hennekens, C. H., Buring, J. E., Rifai, N. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836843.
  • 11
    Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., Braunwald, E. (2000) Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101: 21492153.
  • 12
    Benjafield, A. V., Wang, X. L., Morris, B. J. (2001) Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease. J Mol Med 79: 109115.
  • 13
    Pradhan, A. D., Manson, J. E., Rifai, N., Buring, J. E., Ridker, P. M. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327334.
  • 14
    Abramson, J. L., Vaccarino, V. (2002) Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 162: 12861292.
  • 15
    Wannamethee, S. G., Lowe, G. D., Whincup, P. H., Rumley, A., Walker, M., Lennon, L. (2002) Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 105: 17851790.
  • 16
    Onat, A., Sansoy, V., Yildirim, B., Keles, I., Uysal, O., Hergenc, G. (2001) C-reactive protein and coronary heart disease in western Turkey. Am J Cardiol 88: 601607.
  • 17
    Geffken, D., Cushman, M., Burke, G., Polak, J., Sakkinen, P., Tracy, R. (2001) Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 153: 242250.
  • 18
    Smith, J. K., Dykes, R., Douglas, J. E., Krishnaswamy, G., Berk, S. (1999) Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 281: 17221727.
  • 19
    Rimm, E. B., Giovannucci, E. L., Willett, W. C., et al (1991) Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 338: 464468.
  • 20
    Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B., Willett, W. C. (1992) Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135: 11141126; discussion 1127–1136.
  • 21
    Chu, N. F., Spiegelman, D., Yu, J., Rifai, N., Hotamisligil, G. S., Rimm, E. B. (2001) Plasma leptin concentrations and four-year weight gain among US men. Int J Obes Relat Metab Disord 25: 346353.
  • 22
    Fung, T. T., Hu, F. B., Yu, J., et al (2000) Leisure-time physical activity, television watching, and plasma biomarkers of obesity and cardiovascular disease risk. Am J Epidemiol 152: 11711178.
  • 23
    Ainsworth, B. E., Haskell, W. L., Leon, A. S., et al (1993) Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25: 7180.
  • 24
    Chasan-Taber, S., Rimm, E. B., Stampfer, M. J., et al (1996) Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology 7: 8186.
  • 25
    Rimm, E. B., Stampfer, M. J., Colditz, G. A., Chute, C. G., Litin, L. B., Willett, W. C. (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1: 466473.
  • 26
    Giovannucci, E., Colditz, G., Stampfer, M. J., et al (1991) The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 133: 810817.
  • 27
    Garland, M., Hunter, D. J., Colditz, G. A., et al (1999) Alcohol consumption in relation to breast cancer risk in a cohort of United States women 25–42 years of age. Cancer Epidemiol Biomarkers Prev 8: 10171021.
  • 28
    Willett, W. C., Sampson, L., Stampfer, M. J., et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122: 5165.
  • 29
    Wolf, A. M., Hunter, D. J., Colditz, G. A., et al (1994) Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 23: 991999.
  • 30
    Pai, J. K., Curhan, G. C., Cannuscio, C. C., Rifai, N., Ridker, P. M., Rimm, E. B. (2002) Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem 48: 17811784.
  • 31
    Durrleman, S., Simon, R. (1989) Flexible regression models with cubic splines. Stat Med 8: 551561.
  • 32
    White, H. (1980) A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 48: 817838.
  • 33
    Moller, L., Kristensen, T. S. (1991) Plasma fibrinogen and ischemic heart disease risk factors. Arterioscler Thromb 11: 344350.
  • 34
    Connelly, J. B., Cooper, J. A., Meade, T. W. (1992) Strenuous exercise, plasma fibrinogen, and factor VII activity. Br Heart J 67: 351354.
  • 35
    Folsom, A. R., Conlan, M. G., Davis, C. E., Wu, K. K. (1992) Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults: Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol 2: 481494.
  • 36
    Elwood, P. C., Yarnell, J. W., Pickering, J., Fehily, A. M., O'Brien, J. R. (1993) Exercise, fibrinogen, and other risk factors for ischaemic heart disease: Caerphilly Prospective Heart Disease Study. Br Heart J 69: 183187.
  • 37
    Lakka, T. A., Salonen, J. T. (1993) Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men. J Clin Epidemiol 46: 11191127.
  • 38
    MacAuley, D., McCrum, E. E., Stott, G., et al (1996) Physical activity, physical fitness, blood pressure, and fibrinogen in the Northern Ireland health and activity survey. J Epidemiol Community Health 50: 258263.
  • 39
    Willett, W. (1998) Anthropometric measures and body composition. Willett, W eds. Nutritional Epidemiology 244272. Oxford University Press New York.
  • 40
    Marshall, J. A., Grunwald, G. K., Donahoo, W. T., Scarbro, S., Shetterly, S. M. (2000) Percent body fat and lean mass explain the gender difference in leptin: analysis and interpretation of leptin in Hispanic and non-Hispanic white adults. Obes Res 8: 543552.
  • 41
    Du Clos, T. W. (2000) Function of C-reactive protein. Ann Med 32: 274278.
  • 42
    Tchernof, A., Nolan, A., Sites, C. K., Ades, P. A., Poehlman, E. T. (2002) Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105: 564569.
  • 43
    Corbett, J. A., Sweetland, M. A., Wang, J. L., Lancaster, J. R. Jr, McDaniel, M. L. (1993) Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 90: 17311735.
  • 44
    Aderka, D. (1996) The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7: 231240.
  • 45
    Diez-Ruiz, A., Tilz, G. P., Zangerle, R., Baier-Bitterlich, G., Wachter, H., Fuchs, D. (1995) Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 54: 18.
  • 46
    Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., Wallach, D. (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175: 323329.
  • 47
    De Groote, D., Grau, G. E., Dehart, I., Franchimont, P. (1993) Stabilisation of functional tumor necrosis factor-alpha by its soluble TNF receptors. Eur Cytokine Netw 4: 359362.
  • 48
    Mohler, K. M., Torrance, D. S., Smith, C. A., et al (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151: 15481561.
  • 49
    Fernandez-Real, J. M., Broch, M., Ricart, W., et al (1998) Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 47: 17571762.
  • 50
    Levine, B., Kalman, J., Mayer, L., Fillit, H. M., Packer, M. (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323: 236241.
  • 51
    Ferrari, R., Bachetti, T., Confortini, R., et al (1995) Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92: 14791486.
  • 52
    Rauchhaus, M., Doehner, W., Francis, D. P., et al (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102: 30603067.
  • 53
    Bastard, J. P., Jardel, C., Bruckert, E., et al (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85: 33383342.
  • 54
    Sayeed, M. M. (1996) Alterations in calcium signaling and cellular responses in septic injury. New Horiz 4: 7286.
  • 55
    Stith, R. D., Luo, J. (1994) Endocrine and carbohydrate responses to interleukin-6 in vivo. Circ Shock 44: 210215.
  • 56
    Tsigos, C., Papanicolaou, D. A., Kyrou, I., Defensor, R., Mitsiadis, C. S., Chrousos, G. P. (1997) Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 82: 41674170.